Importance of Serum Biomarkers for Early Diagnosis of Acute Ischemic Stroke: What’s New

Abstract

133 Copyright 2023 The Emergency Physicians Association of Turkey / Eurasian Journal of Emergency Medicine published by Galenos Publishing House. Licenced by Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) 4.0 International License. Cite this article as: Kumar N. xxx Eurasian J Emerg Med. Eurasian J Emerg Med. Eurasian J Emerg Med. 2023;22(3): 133-4. Ischemic and hemorrhagic strokes are two important components of strokes and globally these strokes are the leading cause of mortality and long-term disability (1). Acute ischemic strokes (AIS) have a greater incidence than hemorrhagic strokes and they present with sudden onset of acute neurological deterioration. The outcome of these stroke patients depends on early and prompt diagnosis at the time of admission and quick restoration of normal cerebral blood flow required (2). Globally more than 12.2 million new strokes each year and one in four people over age 25 will have a stroke in their lifetime. Over 62% of all incident strokes are ischaemic strokes (3).